Keay Nakae
Stock Analyst at Chardan Capital
(3.00)
# 1,341
Out of 4,840 analysts
230
Total ratings
29.02%
Success rate
3.63%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SABS SAB Biotherapeutics | Maintains: Buy | $20 | $1.81 | +1,004.97% | 15 | May 15, 2025 | |
| OBIO Orchestra BioMed Holdings | Maintains: Buy | $20 | $2.73 | +632.60% | 10 | May 13, 2025 | |
| KRRO Korro Bio | Maintains: Buy | $25 | $13.80 | +81.16% | 2 | May 13, 2025 | |
| COYA Coya Therapeutics | Maintains: Buy | $14 | $5.75 | +143.48% | 18 | May 13, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $60 | $15.13 | +296.56% | 19 | May 13, 2025 | |
| DYN Dyne Therapeutics | Maintains: Buy | $50 | $11.70 | +327.53% | 11 | May 9, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $65 | $30.58 | +112.56% | 16 | May 9, 2025 | |
| SLN Silence Therapeutics | Maintains: Buy | $55 → $35 | $5.06 | +591.70% | 11 | May 9, 2025 | |
| MCRB Seres Therapeutics | Downgrades: Neutral | $1.25 → $6 | $7.67 | -21.77% | 10 | May 8, 2025 | |
| IBIO iBio, Inc. | Maintains: Buy | $5 | $0.82 | +511.25% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $325 | $289.96 | +12.08% | 13 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 | $1.13 | +1,669.91% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $1.80 | +233.33% | 7 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $3.22 | +55.28% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2.5 | $2.79 | -10.39% | 6 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $1.67 | +139.52% | 14 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $1.04 | +669.23% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.13 | - | 5 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $6 | $10.83 | -44.57% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $20 | $0.52 | +3,756.54% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $55 | $6.40 | +759.38% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.25 → $10 | $10.05 | -0.50% | 5 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $100 → $88 | $8.49 | +930.62% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $0.7 → $13 | $0.93 | +1,296.65% | 3 | Feb 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $155 → $40 | $3.35 | +1,094.03% | 2 | Jun 30, 2020 |
SAB Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $20
Current: $1.81
Upside: +1,004.97%
Orchestra BioMed Holdings
May 13, 2025
Maintains: Buy
Price Target: $20
Current: $2.73
Upside: +632.60%
Korro Bio
May 13, 2025
Maintains: Buy
Price Target: $25
Current: $13.80
Upside: +81.16%
Coya Therapeutics
May 13, 2025
Maintains: Buy
Price Target: $14
Current: $5.75
Upside: +143.48%
Arrowhead Pharmaceuticals
May 13, 2025
Maintains: Buy
Price Target: $60
Current: $15.13
Upside: +296.56%
Dyne Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $50
Current: $11.70
Upside: +327.53%
Avidity Biosciences
May 9, 2025
Maintains: Buy
Price Target: $65
Current: $30.58
Upside: +112.56%
Silence Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $55 → $35
Current: $5.06
Upside: +591.70%
Seres Therapeutics
May 8, 2025
Downgrades: Neutral
Price Target: $1.25 → $6
Current: $7.67
Upside: -21.77%
iBio, Inc.
May 6, 2025
Maintains: Buy
Price Target: $5
Current: $0.82
Upside: +511.25%
May 2, 2025
Maintains: Buy
Price Target: $300 → $325
Current: $289.96
Upside: +12.08%
Apr 7, 2025
Maintains: Buy
Price Target: $20
Current: $1.13
Upside: +1,669.91%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $1.80
Upside: +233.33%
Mar 28, 2025
Maintains: Buy
Price Target: $5
Current: $3.22
Upside: +55.28%
Mar 27, 2025
Maintains: Neutral
Price Target: $2.5
Current: $2.79
Upside: -10.39%
Mar 14, 2025
Maintains: Buy
Price Target: $4
Current: $1.67
Upside: +139.52%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $1.04
Upside: +669.23%
Feb 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.13
Upside: -
Aug 4, 2023
Maintains: Sell
Price Target: $8 → $6
Current: $10.83
Upside: -44.57%
Nov 10, 2022
Maintains: Buy
Price Target: $60 → $20
Current: $0.52
Upside: +3,756.54%
Nov 9, 2022
Maintains: Buy
Price Target: $65 → $55
Current: $6.40
Upside: +759.38%
Aug 16, 2022
Maintains: Neutral
Price Target: $1.25 → $10
Current: $10.05
Upside: -0.50%
Sep 20, 2021
Upgrades: Neutral
Price Target: $100 → $88
Current: $8.49
Upside: +930.62%
Feb 9, 2021
Downgrades: Neutral
Price Target: $0.7 → $13
Current: $0.93
Upside: +1,296.65%
Jun 30, 2020
Downgrades: Neutral
Price Target: $155 → $40
Current: $3.35
Upside: +1,094.03%